Aprea Therapeutics stock price
NASDAQ:APRE · Nasdaq · Healthcare · sector #16$0.5603-0.16%Oct 21 close
Loading chart…
Aprea Therapeutics's chart data is dated 2026-10-21. There is no active technical signal. The display ticker is APRE.
Aprea Therapeutics last closed at $0.5603 (-0.16%) on 2026-10-21. Listed on Nasdaq. Trailing 12 months PER is -2.4×. Its overall grade ranks 498 of 727 stocks in Healthcare.
About this company
Aprea Therapeutics last closed at $0.5603 (-0.16%) on 2026-10-21. Listed on Nasdaq.
Details →Reported results
Details →
Position in sector
Healthcare · Overall C+ · 498/727
Valuation grade C
Related stocks
- AstraZenecaCompetitor
- Merck & CoCompetitor
- Bristol Myers SquibbCompetitor
About Aprea Therapeutics
- What technical signals does Aprea Therapeutics (APRE) have?
- Aprea Therapeutics current technical signals: no active technical signal.
- Is Aprea Therapeutics a cup-and-handle pattern?
- No. Aprea Therapeutics has no valid Cup signal right now.
- What published figures are available for Aprea Therapeutics?
- Market cap: $3.54M. Trailing 12 months PER: -2.4×. Latest quarter PBR: 0.78×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-22 dataset
Turn what you saw on this name into a strategy
Ask Q about Aprea Therapeutics, or open the plan table on the main site.
Ask Q about Aprea Therapeutics.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.
Quantus Signal · live data · not investment advice · Privacy Policy